Prescription Required
Formulation: Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Requip contains the active ingredient ropinirole. It is a prescription medication used to treat Parkinson’s disease and moderate-to-severe primary restless legs syndrome.
Requip can help manage the movement-related symptoms of Parkinson’s disease, including tremors, muscle stiffness, slowed movement, and difficulty walking or completing everyday activities.
Parkinson’s disease occurs when certain brain cells do not produce enough dopamine. Dopamine is a natural chemical that helps the brain control smooth, coordinated movement.
Requip may be used on its own during the earlier stages of Parkinson’s disease or together with levodopa and other medications as the condition progresses. It helps control symptoms, but it does not cure Parkinson’s disease or stop the condition from progressing.
Requip is also used to treat moderate-to-severe primary restless legs syndrome, commonly called RLS.
RLS causes an uncomfortable urge to move the legs, often with crawling, tingling, pulling, aching, or burning sensations. Symptoms usually become worse while resting, sitting, or lying down and are often most noticeable in the evening or at night.
Moving or stretching the legs may provide temporary relief. Requip can reduce uncomfortable leg sensations, decrease the urge to move, and make it easier to rest or sleep.
Primary RLS means that the symptoms are not directly caused by another medical condition or medication. Requip may not be appropriate when restless legs symptoms are related to iron deficiency, kidney disease, pregnancy, nerve damage, or another underlying cause.
Requip belongs to a group of medications called dopamine agonists. It works by stimulating dopamine receptors in the brain and acting in a way similar to natural dopamine.
In Parkinson’s disease, this action helps improve the brain signals responsible for movement. It may reduce stiffness, tremors, slowed movement, and difficulty with coordination.
In restless legs syndrome, stimulating dopamine receptors helps regulate the nerve signals associated with uncomfortable leg sensations and the urge to move.
Requip does not replace dopamine in the brain. Instead, it imitates some of dopamine’s effects by activating the same receptors.
Although dopamine is involved in several brain functions, Requip is prescribed primarily for its effects on movement and restless legs symptoms. It is not approved as a treatment for mood disorders.
Requip contains the active ingredient ropinirole. It belongs to a group of medications called dopamine agonists, which stimulate dopamine receptors in the brain.
Requip is prescribed for two main conditions: Parkinson’s disease and moderate-to-severe primary restless legs syndrome. However, the approved use depends on whether the medication is an immediate-release or extended-release tablet.
Requip is used to manage symptoms of Parkinson’s disease, including tremors, muscle stiffness, slowed movement, difficulty walking, and problems with coordination.
It may be prescribed on its own during the earlier stages of Parkinson’s disease or used with levodopa and other Parkinson’s medications. Requip helps control symptoms, but it does not cure Parkinson’s disease or stop it from progressing.
The usual starting dose of immediate-release Requip is 0.25 mg three times daily.
The dose is normally increased gradually during the first four weeks:
After week four, the total daily dose may be increased by 1.5 mg each week until it reaches 9 mg per day. If additional symptom control is needed, the dose may then be increased by up to 3 mg per day at weekly intervals.
The maximum recommended dose is 24 mg per day, usually taken as 8 mg three times daily.
Extended-release ropinirole is taken once daily and is used only for Parkinson’s disease.
The usual starting dose is 2 mg once daily for one to two weeks. Your healthcare provider may then increase the dose by 2 mg per day at weekly or longer intervals, depending on how well the medication works and whether you experience side effects.
The maximum recommended dose is 24 mg once daily. Extended-release tablets must be swallowed whole and should not be crushed, chewed, or divided.
Immediate-release and extended-release tablets are not interchangeable dose for dose without medical supervision. Your healthcare provider must provide instructions when changing from one form to the other.
Immediate-release Requip is used to treat moderate-to-severe primary restless legs syndrome, commonly called RLS.
RLS causes uncomfortable sensations in the legs and a strong urge to move them. Symptoms are usually worse when resting and commonly occur during the evening or at night.
Requip may reduce the uncomfortable sensations, decrease the urge to move, and make it easier to rest or sleep. Extended-release ropinirole is not approved for treating RLS.
The usual starting dose is 0.25 mg once daily, taken one to three hours before bedtime.
The dose may be gradually increased according to the following schedule:
The maximum recommended dose for RLS is 4 mg once daily. Not everyone needs the maximum dose. Your healthcare provider will choose the lowest dose that adequately controls your symptoms.
Requip may be taken with or without food. Taking it with food may help reduce nausea or stomach discomfort.
Take each dose at approximately the same time every day. For RLS, take it one to three hours before bedtime rather than waiting until symptoms become severe.
Your healthcare provider will start you on a low dose and increase it gradually. This helps reduce the risk of nausea, dizziness, fainting, low blood pressure, hallucinations, and excessive sleepiness.
People with moderate kidney impairment generally do not require an adjustment to the starting dose.
For people receiving regular hemodialysis, lower maximum doses are recommended. The maximum is generally 18 mg per day for Parkinson’s disease and 3 mg once daily for restless legs syndrome. An additional dose after dialysis is not usually required.
The use of ropinirole has not been adequately studied in people with severe kidney impairment who are not receiving regular dialysis.
Do not increase your dose on your own, even if your symptoms are not improving. Higher doses can increase the risk of serious sleepiness, sudden sleep episodes, dizziness, fainting, hallucinations, uncontrolled movements, and compulsive behaviours.
Do not suddenly stop taking Requip. Abruptly stopping or quickly reducing the dose can cause worsening symptoms and potentially serious withdrawal reactions. Your healthcare provider will normally reduce the dose gradually.
Contact your healthcare provider before restarting Requip if your treatment has been interrupted for more than a brief period. You may need to restart at a lower dose and gradually increase it again.
Requip (Ropinirole) is available in the following forms and strength:
Requip may interact with other medications. Before starting treatment, tell your healthcare provider and pharmacist about every prescription medication, over-the-counter product, vitamin, and herbal supplement you take.
Ciprofloxacin and certain other medications that block the CYP1A2 liver enzyme may increase the amount of ropinirole in your blood. This can increase side effects such as nausea, dizziness, low blood pressure, hallucinations, and excessive sleepiness. Your healthcare provider may need to adjust your Requip dose or monitor you more closely.
Estrogen-containing medications, including some hormone-replacement therapies, may also increase ropinirole levels. Tell your healthcare provider when starting or stopping estrogen treatment because your Requip dose may need to be reviewed.
Medications that block dopamine, including metoclopramide and certain antipsychotic medications, may reduce how well Requip works. Other medicines that cause drowsiness can increase the risk of severe sleepiness or suddenly falling asleep during everyday activities.
When Requip is taken with levodopa, it may increase involuntary or uncontrolled movements, called dyskinesia. If this occurs, your healthcare provider may need to adjust your levodopa or Requip dose.
Alcohol can increase nervous-system side effects such as dizziness, drowsiness, poor concentration, and impaired judgment. It may also increase the possibility of suddenly falling asleep.
Avoid or limit alcohol while taking Requip. Do not drive, operate machinery, or perform another potentially dangerous activity until you know how the medication affects you.
Do not take Requip if you have previously had an allergic reaction to ropinirole or any ingredient in the medication.
Seek emergency medical attention if you develop difficulty breathing or swallowing; hives; a severe rash; or swelling of your face, lips, tongue, or throat. These symptoms may indicate a serious allergic reaction.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. There is not enough information from pregnant patients to determine the medication’s risks clearly, so Requip should only be used during pregnancy when your healthcare provider decides that its potential benefits justify the possible risks.
It is not known whether ropinirole passes into human breast milk. Ropinirole may also reduce prolactin, a hormone involved in milk production, and could potentially reduce the amount of breast milk produced. Your healthcare provider can help determine whether to use Requip or breastfeed.
Older adults may be more sensitive to certain side effects of Requip, particularly hallucinations, confusion, dizziness, low blood pressure, and excessive sleepiness.
A lower dose is not automatically required based on age alone. However, treatment is normally started at a low dose and increased carefully according to the person’s response and side effects.
Some people taking Requip develop intense urges that are unusual for them. These may include compulsive gambling, excessive shopping, binge eating, or increased sexual urges.
The person taking Requip may not always recognize these changes. Family members and caregivers should also watch for unusual behaviour. Contact your healthcare provider promptly if new or uncontrollable urges develop. Reducing the dose or stopping the medication under medical supervision may help.
Do not suddenly stop taking Requip or reduce your dose without medical guidance. Your healthcare provider will normally lower the dose gradually.
Withdrawal symptoms may include difficulty sleeping, lack of motivation, anxiety, depression, fatigue, sweating, and pain. Rarely, suddenly stopping or rapidly reducing Requip may cause a serious reaction involving fever, severe muscle stiffness, confusion, or changes in consciousness. Seek urgent medical care if these symptoms occur.
The use of ropinirole has not been adequately studied in people with liver impairment. Because the liver helps remove ropinirole from the body, liver problems could potentially increase medication levels and the risk of side effects.
Tell your healthcare provider if you have liver disease or abnormal liver-test results. Your dose may need to be increased more cautiously, and you may require closer monitoring.
Requip can interact with certain medications. Before starting treatment, tell your healthcare provider and pharmacist about every prescription medication, over-the-counter product, vitamin, and herbal supplement you take. Certain antipsychotic medications and nausea medicines, such as metoclopramide, may reduce how well Requip works because they block dopamine. Other medications, including ciprofloxacin, estrogen-containing products, and medicines that cause drowsiness, may increase the amount of ropinirole in your body or increase the risk of side effects. When Requip is taken with levodopa, it may increase involuntary or uncontrolled movements. Your healthcare provider may need to adjust one or both medications. Do not start, stop, or change any medication without first checking with your healthcare provider or pharmacist.
Take Requip by mouth exactly as prescribed. It may be taken with or without food, although taking it with food may help reduce nausea. The dose and timing depend on the condition being treated and the type of tablet prescribed. For Parkinson’s disease, immediate-release Requip is usually taken three times daily. Extended-release ropinirole is normally taken once daily and should be swallowed whole. For restless legs syndrome, immediate-release Requip is usually taken once daily, approximately one to three hours before bedtime. Take each dose at approximately the same time every day. Do not take more medication or increase your dose unless your healthcare provider instructs you to do so.
The amount of time Requip takes to work varies from person to person and depends on the condition being treated. Some people may notice an improvement in symptoms within several days. However, it may take several weeks to find the dose that provides the best symptom control because Requip is usually started at a low dose and increased gradually. Continue taking it as prescribed, even if you do not notice an immediate improvement. Contact your healthcare provider if your symptoms do not improve or become worse.
Yes. Requip may be used in older adults. However, older patients may be more sensitive to certain side effects, including dizziness, confusion, hallucinations, low blood pressure, excessive sleepiness, and falls. A lower dose is not automatically required because of age alone, but treatment is usually started at a low dose and increased carefully. Healthcare providers may monitor older adults more closely for side effects and changes in behaviour.
Yes. Requip may be used for long-term symptom management when it continues to provide benefits and the side effects remain manageable. Some people with Parkinson’s disease may take it for several years. Regular follow-up appointments are important during long-term treatment. Your healthcare provider may review how well the medication is working and check for excessive sleepiness, hallucinations, low blood pressure, involuntary movements, compulsive behaviours, or other side effects. In people taking Requip for restless legs syndrome, symptoms may occasionally begin earlier in the day, become stronger, or spread to other parts of the body. This is called augmentation and should be reported to your healthcare provider. Do not suddenly stop taking Requip. Your healthcare provider will normally reduce the dose gradually to lower the risk of withdrawal symptoms or a sudden worsening of your condition.
| Generic name: | Ropinirole |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 0.5mg, 0.25mg, 1mg, 2mg |
| Quantities Available: | 60, 84, 90, 100, 200 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Requip (ropinirole) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Requip is commonly prescribed in dosages of to 1 mg or 2 mg, taken once daily or multiple times daily depending on the condition and individual response.
For example, if prescribed 1 mg three times daily, for a 90-day supply, you would order 270 tablets (90 days x 3 tablets per day).
Yes, we sell ropinirole on our website, and you can enjoy low prices. To purchase ropinirole, you will need a valid prescription from your healthcare provider. We require this to dispense the medication. You can conveniently submit your prescription by mail, fax, or upload it through your online account to facilitate the ordering process.
Yes, we ship Requip (ropinirole) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Requip (Ropinirole). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Requip (Ropinirole).
REVIEWS